About Microvisk
Microvisk is a company based in Saint Asaph (United Kingdom) founded in 2004.. Microvisk has raised $16.62 million across 3 funding rounds from investors including Oxford Technology, New Hill Management and Development Bank of Wales. Microvisk operates in a competitive market with competitors including Accriva Diagnostics, Diagnostica Stago, Enzyre, Entegrion and Perosphere, among others.
- Headquarter Saint Asaph, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Microvisk Limited
- Date of Incorporation 05 Feb, 2004
- Jurisdiction GUILDFORD, SURREY, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.62 M (USD)
in 3 rounds
-
Latest Funding Round
$9.53 M (USD), Series B
Jan 26, 2011
-
Investors
Oxford Technology
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Microvisk
Microvisk has successfully raised a total of $16.62M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $9.53 million completed in January 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $9.5M
-
First Round
First Round
(28 Jan 2010)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2011 | Amount | Series B - Microvisk | Valuation |
investors |
|
| Sep, 2010 | Amount | Series A - Microvisk | Valuation |
investors |
|
| Jan, 2010 | Amount | Series A - Microvisk | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Microvisk
Microvisk has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Oxford Technology, New Hill Management and Development Bank of Wales. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage micro-VC investments are focused on UK companies.
|
Founded Year | Domain | Location | |
|
Limited information is provided about New Hill Management's activities.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Microvisk
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Microvisk
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Microvisk Comparisons
Competitors of Microvisk
Microvisk operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accriva Diagnostics, Diagnostica Stago, Enzyre, Entegrion and Perosphere, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Near-patient diagnostic systems for coagulation testing are developed.
|
|
| domain | founded_year | HQ Location |
A portfolio of hemostasis and coagulation diagnostic products is manufactured.
|
|
| domain | founded_year | HQ Location |
Smart diagnostics devices for blood coagulation analysis are developed.
|
|
| domain | founded_year | HQ Location |
Hemostasis and fluid replacement products are provided for medical applications.
|
|
| domain | founded_year | HQ Location |
Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Microvisk
When was Microvisk founded?
Microvisk was founded in 2004 and raised its 1st funding round 6 years after it was founded.
Where is Microvisk located?
Microvisk is headquartered in Saint Asaph, United Kingdom. It is registered at Saint Asaph, Denbighshire, United Kingdom.
Is Microvisk a funded company?
Microvisk is a funded company, having raised a total of $16.62M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3.23M, raised on Jan 28, 2010.
What does Microvisk do?
Microvisk was founded in 2004 and is headquartered in Saint Asaph, United Kingdom. Operations center on the medical device sector, where a handheld tool known as Coagmax is developed to assess blood clots and glucose levels. This product incorporates micro electro-mechanical systems (MEMS) integrated with disposable smart chips for point-of-care diagnostics. Focus remains on advancing portable health monitoring technologies.
Who are the top competitors of Microvisk?
Microvisk's top competitors include Accriva Diagnostics, Diagnostica Stago and Enzyre.
Who are Microvisk's investors?
Microvisk has 6 investors. Key investors include Oxford Technology, New Hill Management, Development Bank of Wales, Porton Group, and UKI2S.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.